TNON Stock Analysis: Buy, Sell, or Hold?
TNON - Tenon Medical, Inc. Common Stock
$6.32
-0.51 (-7.47%)
▼
5d:
+28.46%
30d:
+3229.82%
90d:
+780.84%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When TNON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TNON is 21.8% above its trading range ($5.19). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TNON is 21.8% above its trading range ($5.19). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TNON is currently trading at $6.32, which is considered extended relative to its 30-day fair value range of $-0.94 to $5.19.
Technical Outlook: Technically, TNON is in a uptrend. Immediate support is located at $4.78, while resistance sits at $17.84. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: TNON scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $44.38 (+527.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNON is in a uptrend. Immediate support is located at $4.78, while resistance sits at $17.84. Short-term momentum is weak, with the stock down 7.5% recently.
Market Sentiment: TNON scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $44.38 (+527.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$-0.94 -
$5.19
Company Quality Score
33/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
10.5%
All Signals
- BEARISH: Price significantly overextended (+21.8% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.5%)
- BULLISH: Trading 527.7% below Wall St target ($44.38)
- WARNING: Composite score 33/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$-0.94 -
$5.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.78
Resistance Level
$17.84
Current Trend
Uptrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.59
Wall Street Target
$44.38
(+527.7%)
Revenue Growth (YoY)
126.8%
Profit Margin
-257.9%
Share & Embed Analysis
Last updated: August 24, 2026 3:26 PM ET
Data refreshes hourly during market hours. Next update: 4:26 PM
Data refreshes hourly during market hours. Next update: 4:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 46 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 60 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 45 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 54 HOLD |
